BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Aspirin, rs2300478, SNCA, cell-cell adhesion, Ischemia, Prostate, Amniocentesis)
Bookmark Forward

QuickView for negative regulation of transcription by competitive promoter binding (biogroup)


Body Atlas

Most Correlated Tissues

  1. Adrenal gland cortex
  2. Urethra
  3. Endometrium
  4. Adipose tissue
  5. Breast tissue
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Multiple-resistant Staphylococcus aureus infection
  2. 11p partial monosomy syndrome
  3. Barrett's esophagus
  4. Esophagitis
  5. Pyloric ulcer
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CP 724714
  2. regorafenib
  3. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  4. flavopiridol
  5. AST-1306
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. PCDH11X
  2. PPIC
  3. FN1
  4. CCNB1
  5. Mir10a
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
  2. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  4. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
  5. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for negative regulation of transcription by competitive promoter binding
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
  2. Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
  3. Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resi…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.